Yang et al. (16) found C20:1 or erucate (C22:1) was equally effective in reducing atherosclerosis in LDLr mice through activation of the Ppar signaling pathways and favorable alterations in the proteome of lipoproteins. The gene discussed is PPARA; the disease is atherosclerosis.